Second-Quarter Consumer Health Results Bring J&J Relief From Year-Ago Sales Plummet
Segment's Results Likely Better Than Remainder Of 2021, J&J And Analyst Say
In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.
